InvestorsHub Logo
Followers 51
Posts 3078
Boards Moderated 0
Alias Born 05/11/2016

Re: None

Thursday, 08/31/2017 5:57:35 AM

Thursday, August 31, 2017 5:57:35 AM

Post# of 19459
https://www.geovax.com/clinical-pipeline.html



GOVX Market cap is 2.2 Million
GOVX is trading .03 Cents


Not for Long you can make book on that!



GOVX 68 Million Shares.



GOVX has about a Million in Cash gets lots of funding from government agencies.



10% held by Insiders including Emory University.


This stock should be trading at least a $1.00+ They have one of the furthest HIV Vaccine in the world up to Phase 2B tested on 100's of patients and having a single shot Functional Cure Trial Starting in the next couple months.

IN ALL MY YEARS OF INVESTING I HAVE NEVER SEEN A DEEP PIPELINE LIKE THIS WITH A MARKET CAP UNDER 100 MILLION.


And Farshad Guirakhoo, Ph.D., Chief Scientific Officer for GOVX is rated #22 in the world


Thomas P. Monath, MD, (Chairman) Scientific Advisory Board # 2 Top Most Influential Vaccine Scientist in the world.



Stanley A. Plotkin Scientific Advisory Board , MD #5 Top Most Influential Vaccine Scientist in the world.


http://vaxess.com/wp-content/uploads/2016/01/the-most-influential-people-in-vaccines.pdf


GOVX has three of the top 50 influential vaccine scientist in the world.


Plus Harriet Robinson One of the top HIV Researchers in the world she helped start this company with Emory University.


https://www.geovax.com/the-need-for-an-hiv-aids-vaccine.html


11 Vaccines in Clinical Trials.



Including a single shot Zika Virus, Ebola, Malaria Hep B, Marburg and Lassa fever viruses. .



And Cancer Immunotherapy Vaccines in the works.



I can see this stock moving 5,000-10,000%+ from these levels or higher..


I own over a Million Shares and see myself making a fortune here.



$GOVX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News